v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net income (loss) including noncontrolling interests $ (17,164) $ 22,153
Adjustments to reconcile net income (loss) to net cash from operating activities:    
Depreciation and amortization 21,423 20,926
Share-based compensation expenses related to equity classified awards 6,097 5,757
Non-cash restructuring and other related charges 0 3,470
Amortization and write-off of program rights 206,262 197,881
Amortization of deferred carriage fees 2,588 6,885
Unrealized foreign currency transaction (gain) loss 3,765 (3,329)
Amortization of deferred financing costs and discounts on indebtedness 1,762 1,969
Deferred income taxes 9,512 (10,675)
Other, net (3,373) (3,928)
Changes in assets and liabilities:    
Accounts receivable, trade (including amounts due from related parties, net) 20,853 53,204
Prepaid expenses and other assets (7,300) 12,658
Program rights and obligations, net (167,708) (169,605)
Deferred revenue (218) (1,296)
Accounts payable, accrued liabilities and other liabilities (9,032) (27,265)
Net cash provided by operating activities 67,467 108,805
Cash flows from investing activities:    
Capital expenditures (2,652) (14,620)
Net cash used in investing activities (2,652) (14,620)
Cash flows from financing activities:    
Principal payments on Term Loan A Facility (2,767) (8,125)
Payments for financing costs (2,000) 0
Deemed repurchases of restricted stock units (6,598) (3,643)
Principal payments on finance lease obligations (455) (1,198)
Net cash used in financing activities (11,820) (12,966)
Net increase in cash and cash equivalents from operations 52,995 81,219
Effect of exchange rate changes on cash and cash equivalents (3,237) 4,361
Cash and cash equivalents at beginning of period 502,379 784,649
Cash and cash equivalents at end of period $ 552,137 $ 870,229